Is Needham Considered MM?
Thinking of applying to their open listings, curious about what people's opinions are about the bank.
Interested in their healthcare and tech practice.
Thinking of applying to their open listings, curious about what people's opinions are about the bank.
Interested in their healthcare and tech practice.
| +150 | Senior Banker's Guide to IB Recruiting / Group Placement (with a Healthcare Bent) | 19 | 2h |
| +120 | Is pay at BofA really that bad? | 60 | 7h |
| +97 | As Lehman people reconvene at UBS, Barclays needs to hire (2023) | 18 | 1h |
| +88 | Day at Macquarie | 12 | 7h |
| +44 | Is the life of a VP at a 'top-bank' really good? | 15 | 3d |
| +44 | How bad did I mess up | 10 | 13h |
| +31 | Misrepresented Houston IB | 14 | 18h |
| +29 | Law school instead of MBA for RX Banking | 6 | 11h |
| +29 | No BB RO 2026 | 10 | 2d |
| +28 | JPM SMALL CAP or WF/JEF/RBC Coverage group | 13 | 3h |
Career Resources
Below MM. barley a bank. far right co manager on $75mm life sci FOs
LMM
No
Regional or LMM. MM would be Truist / Lincoln / Stifel etc and UMM would be Baird / Blair / HL / HW. Needham doesn’t compete with any of these.
why would those 4 be considered UMM? that implies jeff/gugg/roths are something above UMM
How are the HC and Tech groups in 2026?
Would not give too much weight to the comments above (perhaps just outdated). Although the firm is smaller and more “boutique-y” in total size (~200 employees across all offices), they definitely punch above their weight class in terms of output.
On the ECM side, they made it into the SpaceX and SK Hynix IPOs, of which many of the firms above and other competitors (TD Cowen, Jefferies, etc.) did not. Though these are typically smaller passive roles on the larger mega deals, they are frequently lead-left / active book on smaller offerings.
M&A is office/sector dependent, though overall not a volume shop like HL or Lincoln by any means. Boston and SF have recently closed numerous solidly 9-figure semiconductor / quantum deals, though majority otherwise can be considered MM/LMM M&A ($50M - $150M). Tech is much stronger than healthcare as a product of greater headcount / MDs on the tech side.
Firm is coming off a strong year in 2025 with extremely solid momentum in 2026. Overall it’s a solid sector-focused MM shop that often flies under the radar but has strong senior tenure and solid junior culture. Feel like there’s not a lot on here about the firm and saw the thread pop up so figured I’d chime in.
Source: I work here
Dolor magnam quod odio perferendis velit. Aut minus nemo debitis eos. Rerum omnis doloremque consequatur eaque ut placeat qui. Aliquid repellat est cum blanditiis aut assumenda quod.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...